| |
| |
|
| Insider
Information: |
Tatsis Ourania |
| Relationship: |
EVP, Chief Reg. & Qual... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,804 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,723,962 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,804 |
|
|
| Total
Value |
$24,723,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Reg. & Qual... |
2024-02-26 |
55,804 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-01-08 |
4 |
OE |
$187.53 |
$314,113 |
D/D |
1,675 |
8,927 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-06 |
4 |
OE |
$155.57 |
$168,302 |
D/D |
967 |
17,913 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Regulatory Officer |
• – – |
2020-05-06 |
4 |
OE |
$155.57 |
$168,146 |
D/D |
966 |
13,704 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CROOfficer |
• – – |
2019-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,884 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-17 |
4 |
D |
$241.50 |
$144,176 |
D/D |
(597) |
16,349 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-24 |
4 |
D |
$239.23 |
$247,842 |
D/D |
(1,036) |
14,034 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$263,417 |
D/D |
(1,230) |
34,468 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2021-02-17 |
4 |
D |
$211.75 |
$423,500 |
D/D |
(2,000) |
32,468 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$225,403 |
D/D |
(1,036) |
31,432 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-02-10 |
4 |
D |
$237.74 |
$292,420 |
D/D |
(1,230) |
58,027 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-02-17 |
4 |
D |
$232.51 |
$956,546 |
D/D |
(4,114) |
53,623 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-02-24 |
4 |
D |
$227.86 |
$590,157 |
D/D |
(2,590) |
50,514 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-10 |
4 |
D |
$294.33 |
$405,292 |
D/D |
(1,377) |
69,035 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$893,289 |
D/D |
(2,995) |
66,040 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-17 |
4 |
D |
$292.85 |
$1,317,239 |
D/D |
(4,498) |
60,947 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$956,409 |
D/D |
(3,308) |
57,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$887,754 |
D/D |
(2,100) |
68,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
63,680 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
60,307 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$1,428,793 |
D/D |
(3,309) |
56,158 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-10-01 |
4 |
AS |
$169.11 |
$31,793 |
D/D |
(188) |
7,696 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-10-02 |
4 |
AS |
$167.69 |
$74,454 |
D/D |
(444) |
7,252 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2019-11-15 |
4 |
AS |
$205.95 |
$1,030 |
D/D |
(5) |
7,252 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-01-08 |
4 |
AS |
$227.53 |
$381,113 |
D/D |
(1,675) |
7,252 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, CRO |
• – – |
2020-02-06 |
4 |
AS |
$238.77 |
$231,527 |
D/D |
(967) |
16,946 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
